Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Siewert Type I Adenocarcinoma of Esophagogastric Junction”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableStudy completedNCT06277921
What this trial is testing

Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery

Who this might be right for
Esophageal CancerOesophageal CancerSiewert Type I Adenocarcinoma of Esophagogastric Junction+1 more
P. Herzen Moscow Oncology Research Institute 230
Testing effectiveness (Phase 2)Looking for participantsNCT06044311
What this trial is testing

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma EsophagusLocally Advanced AdenocarcinomaSiewert Type I Adenocarcinoma of Esophagogastric Junction+1 more
Sakti Chakrabarti 25
Not applicableUnknownNCT04151524
What this trial is testing

Classification of Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Oesophagus CancerBarrett EsophagusSiewert Type I Adenocarcinoma of Esophagogastric Junction+2 more
St. James's Hospital, Ireland 1,658
Testing effectiveness (Phase 2)Study completedNCT02559687
What this trial is testing

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 121